top of page
pilocideâ„¢ antibacterial skin injections
pilocideâ„¢
antibacterial skin injections
Pilocideâ„¢ is a proprietary platform being developed to prevent and treat bacterial infections associated with skin bacteria. It is based on patent-pending pharmaceutical compositions and medical injection devices. Pilocideâ„¢ treatments suppress hair follicles from releasing bacteria and can be formulated to neutralize bacteria released into a wound. Potential applications include traumatic wounds, surgical incisions, medical device infections, and other diseases and disorders associated with skin bacteria.
our mission
Our mission is to provide more effective and safer treatments for diseases and disorders associated with skin bacteria, reducing the burden on patients, healthcare providers, communities, and the environment.
antibacterial skin injections
pilocideâ„¢
Pilocide™ treatments allow for precise, timely, and effective administration of local antibacterial medications into the skin. Clinically relevant doses of antibacterials are administered directly into the inner layers of the skin—the dermis and/or hypodermis—where hair follicles that harbor approximately 25% of the skin's bacteria reside. This approach allows for the immediate establishment of effective antibacterial activity with microdoses of medication.
easily administered • microdosed • cost-effective • less user error
peer-reviewed publications
clinical evidence
There is robust evidence for injecting local antibacterials into the skin to prevent and treat infections associated with skin bacteria. The methodology has been utilized worldwide among physicians for over thirty years, with efficacy demonstrated in dermatologic and general surgery.
journal club
stay up-to-date with the newest clinical research findings
experience in scientific discovery, development, and commercialization
leadership team
Dr. Cody Chase Cook
Founder and Inventor
Dr. Cody Chase Cook
Founder and Inventor
pilocideâ„¢ antibacterial skin injections
bottom of page